Alan T. McGown

3.4k total citations · 1 hit paper
60 papers, 2.9k citations indexed

About

Alan T. McGown is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alan T. McGown has authored 60 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Alan T. McGown's work include Synthesis and biological activity (15 papers), Click Chemistry and Applications (8 papers) and Cancer therapeutics and mechanisms (7 papers). Alan T. McGown is often cited by papers focused on Synthesis and biological activity (15 papers), Click Chemistry and Applications (8 papers) and Cancer therapeutics and mechanisms (7 papers). Alan T. McGown collaborates with scholars based in United Kingdom, United States and Switzerland. Alan T. McGown's co-authors include Nicholas J. Lawrence, John A. Hadfield, Sylvie Ducki, Allan M. Jordan, David Rennison, Keira Gaukroger, Robin G. Pritchard, Jérémie Fournier Dit Chabert, Steven P. Nolan and Gordon C. Jayson and has published in prestigious journals such as Clinical Cancer Research, Inorganic Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Alan T. McGown

60 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle

1998 570 citations Allan M. Jordan, John A. Hadfield et al. Medicinal Research Reviews profile →

Peers

Countries citing papers authored by Alan T. McGown

Since Specialization

Citations

This map shows the geographic impact of Alan T. McGown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan T. McGown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan T. McGown more than expected).

Fields of papers citing papers by Alan T. McGown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan T. McGown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan T. McGown. The network helps show where Alan T. McGown may publish in the future.

Co-authorship network of co-authors of Alan T. McGown

This figure shows the co-authorship network connecting the top 25 collaborators of Alan T. McGown. A scholar is included among the top collaborators of Alan T. McGown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan T. McGown. Alan T. McGown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fluorescence lifetime imaging of E-combretastatin uptake and distribution in live mammalian cells 2011 ·European Journal of Cancer ·Roger H. Bisby, Stanley W. Botchway, John A. Hadfield, Alan T. McGown, Anthony W. Parker, (unknown)	20
2	An efficient synthesis of paracetamol glucuronide from paracetamol 2010 ·Journal of Chemical Research Synopses ·Richard T. Brown, (unknown), Alan T. McGown, John A. Hadfield	1
3	SynchrotronFTIR analysis of drug treated ovarian A2780 cells: an ability to differentiate cell response to different drugs? 2010 ·The Analyst ·Kevin R. Flower, (unknown), Paul Bassan, (unknown), (unknown), Nicholas P. Lockyer, Alan T. McGown, (unknown), Lisa Vaccari, Peter Gardner	52
4	Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity 2009 ·Bioorganic & Medicinal Chemistry ·Sylvie Ducki, David Rennison, (unknown), (unknown), Jérémie Fournier Dit Chabert, Alan T. McGown, Nicholas J. Lawrence	166
5	The Chemistry and Biology of Antimitotic Chalcones and Related Enone Systems 2005 ·Current Pharmaceutical Design ·Nicholas J. Lawrence, Alan T. McGown	77
6	Regulation of Fibroblast Growth Factor-2 Activity by Human Ovarian Cancer Tumor Endothelium 2005 ·Clinical Cancer Research ·Melissa Whitworth, Alison Backen, Andrew R. Clamp, Godfrey Wilson, Rhona J. McVey, Andreas Friedl, Alan C. Rapraeger, Guido David, Alan T. McGown, Richard Slade, John T. Gallagher, Gordon C. Jayson	25
7	The total synthesis of an aurone isolated from Uvaria hamiltonii: aurones and flavones as anticancer agents 2003 ·Bioorganic & Medicinal Chemistry Letters ·Nicholas J. Lawrence, David Rennison, Alan T. McGown, John A. Hadfield	112
8	Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers 2001 ·Bioorganic & Medicinal Chemistry Letters ·Nicholas J. Lawrence, David Rennison, (unknown), Alan T. McGown, (unknown)	45
9	Cytotoxic michael-type amine adducts of α-methylene lactones alantolactone and isoalantolactone 2001 ·Bioorganic & Medicinal Chemistry Letters ·Nicholas J. Lawrence, Alan T. McGown, (unknown), John A. Hadfield, Robin G. Pritchard	82
10	Development and validation of a high-performance liquid chromatographic assay using solid-phase extraction for the novel antitumor agent pancratistatin in human plasma 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), (unknown), (unknown), (unknown), (unknown), Alan T. McGown	2
11	Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines 1999 ·Anti-Cancer Drugs ·(unknown), (unknown), Philip J Perry, Alan T. McGown	31
12	Development and validation of a sensitive solid-phase extraction and high-performance liquid chromatography assay for the novel antitumour agent CT2584 in human plasma 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), (unknown), (unknown), Malcolm Ranson, Alan T. McGown	2
13	Potent antimitotic and cell growth inhibitory properties of substituted chalcones 1998 ·Bioorganic & Medicinal Chemistry Letters ·Sylvie Ducki, (unknown), John A. Hadfield, (unknown), Nicholas J. Lawrence, Alan T. McGown, David Rennison	323
14	Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle breakdown → 1998 ·Medicinal Research Reviews ·Allan M. Jordan, John A. Hadfield, Nicholas J. Lawrence, Alan T. McGown	570
15	High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction technique 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), Alan T. McGown, (unknown), Gordon C. Jayson, J Prendiville, George R. Pettit, Derek Crowther	9
16	Isolation ofE-1-(4′-Hydroxyphenyl)-but-1-en-2-one fromScutellaria barbata 1996 ·Planta Medica ·Sylvie Ducki, John A. Hadfield, Nicholas J. Lawrence, (unknown), Alan T. McGown, Xiuguo Zhang	40
17	Molecular modeling of the interaction of anthracenyl-amino acid topoisomerase inhibitors with the DNA sequence d(CGTACG) 1996 ·Anti-Cancer Drugs ·Jeffrey L. Cummings, John A. Hadfield, (unknown), Alan T. McGown, John F. Smyth	4
18	Isolation of Paeonol fromArisaema erubescens 1995 ·Planta Medica ·Sylvie Ducki, John A. Hadfield, Nicholas J. Lawrence, Xiuguo Zhang, Alan T. McGown	28
19	The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: An HPLC—dynamic FAB study 1993 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Alan T. McGown, (unknown), (unknown), Brian W. Fox	3
20	Expression of O6-alkylguanine-DNA-alkyltransferase in situ in ovarian and Hodgkin's tumours 1993 ·European Journal of Cancer ·Siow Ming Lee, Martin Harris, (unknown), Alan T. McGown, Michael Bromley, Rhoderick H. Elder, Joseph A. Rafferty, Derek Crowther, Geoffrey P. Margison	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact